Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
复制标题
角化细胞定向硫氧还蛋白-1 转基因小鼠皮肤癌发生增加。
DOI:
10.1093/carcin/bgh195
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Powis,Garth
中科院分区:
文献类型:
--
作者:
Mustacich,Debbie;Wagner,Amary;Williams,Ryan;Bair,Warner;Barbercheck,Loretta;Stratton,StevenP;Bhattacharyya,AchyutK;Powis,Garth
Thioredoxin-1 is a low molecular weight redox protein that protects cells against oxidant damage. Thioredoxin-1 levels are increased in the epidermal layer of sun-damaged human skin. Thioredoxin-1 levels are also increased in several human primary tumors where its expression is associated with increased tumor cell proliferation, decreased apoptosis and aggressive tumor growth. We have investigated whether increased thioredoxin-1 levels in skin can lead to increased tumor formation using transgenic mice with mouse thioredoxin-1 expressed in keratinocytes under the control of the keratinocyte-14 (K14) promoter. Thioredoxin-1 protein expression was increased 2-fold in the keratinocyte layer of the transgenic mice. The skin was macroscopically and histologically normal but in the two-stage model of carcinogenesis using topical dimethylbenzanthracene (DMBA) as an initiator and 12-O-tetradecanoylphorbol-13-acetate (TPA) as a promoting agent, there was a 6-fold increase in the number of papillomas per mouse and a 3-fold increase in papilloma size in the K14 thioredoxin-1 transgenic mice compared with non-transgenic littermates. Thus, increased thioredoxin-1 in keratinocytes acts as an enhancer of carcinogenesis in the DMBA/TPA two-stage model of skin carcinogenesis in mice.